Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 191,124 | 179,690 | 382,515 | 122,131 | 123,508 |
| Marketable Securities | 245,174 | 283,544 | 139,129 | 149,599 | 146,866 |
| Receivables | 6,608 | 16,592 | 8,013 | 5,670 | 4,398 |
| Other current assets | 0 | 0 | 0 | 125 | 180 |
| TOTAL | $457,371 | $490,353 | $539,127 | $286,144 | $317,095 |
| Non-Current Assets | |||||
| PPE Net | 10,808 | 11,247 | 11,499 | 11,555 | 11,837 |
| Investments And Advances | 14,315 | 24,638 | 23,466 | 54,132 | 73,700 |
| Intangibles | 1,153 | 1,441 | 1,730 | 2,018 | 2,306 |
| Other Non-Current Assets | 39,632 | 41,067 | 42,543 | 43,919 | 74,748 |
| TOTAL | $65,908 | $78,393 | $79,238 | $111,624 | $162,591 |
| Total Assets | $523,279 | $568,746 | $618,365 | $397,768 | $479,686 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,908 | 4,416 | 18,263 | 7,742 | 14,671 |
| Accrued Expenses | 35,478 | 50,042 | 58,833 | 26,469 | 16,130 |
| Other current liabilities | 28,629 | 27,952 | 28,113 | 5,431 | 9,223 |
| TOTAL | $71,726 | $83,158 | $106,104 | $40,581 | $41,755 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 711 | 748 | 895 | 939 | 1,731 |
| Other Non-Current Liabilities | 55,319 | 56,500 | 56,861 | 80,080 | 124,100 |
| TOTAL | $56,236 | $57,395 | $57,801 | $81,263 | $125,212 |
| Total Liabilities | $127,962 | $140,553 | $163,905 | $121,844 | $166,967 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,848 | 117,708 | 117,276 | 98,917 | 98,707 |
| Common Shares | 12 | 12 | 12 | 10 | 10 |
| Retained earnings | -1,130,468 | -1,073,436 | -1,033,881 | -947,181 | -902,638 |
| Other shareholders' equity | 972 | -233 | 182 | 347 | 405 |
| TOTAL | $395,317 | $428,193 | $454,460 | $275,924 | $312,719 |
| Total Liabilities And Equity | $523,279 | $568,746 | $618,365 | $397,768 | $479,686 |